Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PilOt Dose-escalation Trial With EMP16 in Preparation for Phase III - the POEM Trial

NCT06993428 is registered in ClinicalTrials.gov with Empros Pharma AB as lead sponsor.

NCT NCT06993428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06993428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PilOt Dose-escalation Trial With EMP16 in Preparation for Phase III - the POEM Trial
Lead sponsor
Empros Pharma AB
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 20, 2025
Completion date
July 29, 2025
Enrollment
39 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

obesity and overweight, overweight or obese